Please use this identifier to cite or link to this item:
http://hdl.handle.net/10668/12187
Title: | Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocol. |
Authors: | Gooskens, Saskia L Graf, Norbert Furtwängler, Rhoikos Spreafico, Filippo Bergeron, Christophe Ramírez-Villar, Gema L Godzinski, Jan Rübe, Christian Janssens, Geert O Vujanic, Gordan M Leuschner, Ivo Coulomb-L'Hermine, Aurore Smets, Anne M de Camargo, Beatriz Stoneham, Sara van Tinteren, Harm Pritchard-Jones, Kathy van den Heuvel-Eibrink, Marry M International Society of Paediatric Oncology–Renal Tumour Study Group (SIOP–RTSG) |
metadata.dc.subject.mesh: | Child Clinical Protocols Clinical Trials as Topic Combined Modality Therapy Consensus Humans Kidney Neoplasms Nephrology Sarcoma, Clear Cell Societies, Medical |
Issue Date: | 27-Feb-2018 |
Abstract: | The International Society of Paediatric Oncology-Renal Tumour Study Group (SIOP-RTSG) has developed a new protocol for the diagnosis, treatment, and follow-up monitoring of childhood renal tumours - the UMBRELLA SIOP-RTSG 2016 protocol (the UMBRELLA protocol). This protocol has been designed to continue international collaboration in the treatment of childhood renal tumours and will be implemented in over 50 different countries. Clear cell sarcoma of the kidney, which is a rare paediatric renal tumour that most commonly occurs in children between 2 and 4 years of age, is specifically addressed in the UMBRELLA protocol. |
URI: | http://hdl.handle.net/10668/12187 |
metadata.dc.identifier.doi: | 10.1038/nrurol.2018.14 |
Appears in Collections: | Producción 2020 |
Files in This Item:
There are no files associated with this item.
This item is protected by original copyright |
This item is licensed under a Creative Commons License